Schedules of Controlled Substances Proposed Placement of 3,4-Methylenedioxymethamphetamine into Schedule I, 1984

This is a scanned archival document of a proposed rulemaking issued by Francis M. Mullen, Jr., Acting Administrator of the Drug Enforcement Administration (DEA), originally written on July 20, 1984 and published in the <i>Federal Register</i> on July 27, 1984 (vol. 49, no. 146, pp. 30210–30211). The proposal recommended the placement of 3,4-methylenedioxymethamphetamine (MDMA), also known as an ingredient that may be present in the street drug 'Ecstasy', into Schedule I of the Controlled Substances Act (CSA) due to its high abuse potential, lack of accepted medical use, and insufficient safety profile.The document details the DEA’s rationale, the scientific and medical evaluations submitted by the Department of Health and Human Services, and the procedural steps for scheduling under 21 CFR Part 1308.This version has been uploaded by Octavian Brinzei (2025) for academic, legal, and historical reference. The content is in the public domain as a U.S. government publication.